Analyst Research

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : ValuEngine, Inc.
$49.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

DelMar Pharmaceuticals Inc announces change of fiscal year end


Thursday, 24 Jul 2014 04:07pm EDT 

DelMar Pharmaceuticals Inc:Approves change of the company's fiscal year from Dec. 31 to June 30.Says it will file a Transition Form 10K on or before Sept. 30, 2014. 

Company Quote

0.52
-0.03 -5.44%
31 Jul 2015